Overview

Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian

Status:
Completed
Trial end date:
2021-05-24
Target enrollment:
Participant gender:
Summary
To evaluate the effect of coadministration of aceclofenac, meloxicam and naproxen on pharmacokinetic interactions and safety of JP-1366 in healthy Korean subjects and to compare the pharmacokinetic nature and safety of JP-1366 between healthy Korean and Caucasian.
Phase:
Phase 1
Details
Lead Sponsor:
Onconic Therapeutics Inc.
Treatments:
Aceclofenac
Meloxicam
Naproxen